40 research outputs found

    Physiological, physical and behavioural changes in dogs (Canis familiaris) when kennelled: testing the vailidity of stress parameters

    Get PDF
    Domestic dogs (Canis familiaris) housed in kennelling establishments are considered at risk of suffering poor welfare. Previous research supporting this hypothesis has typically used cortisol:creatinine ratios (C/Cr) to measure acute and chronic stress in kennelled dogs. However, the value of C/Cr as a welfare indicator has been questioned. This study aimed to test the validity of a range of physiological, physical and behavioural welfare indicators and to establish baseline values reflecting good dog welfare. Measurements were taken from 29 privately-owned dogs (14 males, 15 females), ranging in age and breed, in their own home and in a boarding kennel environment, following a within-subjects, counterbalanced design. Pairwise comparisons revealed that C/Cr and vanillylmandelic acid:creatinine ratios (VMA/Cr) were higher in the kennel than home environment (P= 0.003; P= 0.01, respectively) and were not associated with differences in movement/exercise between environments. Dogs' surface temperature was lower in kennels (P= 0.001) and was not associated with ambient temperature. No association with age, or effects of kennel establishment, kennelling experience, sex or source were found. Dogs were generally more active in kennels, but showed considerable individual variability. C/Cr and 5-HIAA:creatinine ratios (5-HIAA/Cr) were negatively correlated with lip licking in kennels. Baseline values for each parameter are presented. The emotional valence of responses was ambiguous and no definitive evidence was found to suggest that dogs were negatively stressed by kennelling. It was concluded that C/Cr and, particularly, VMA/Cr and surface temperature provide robust indicators of psychological arousal in dogs, while spontaneous behaviour might be better used to facilitate interpretation of physiological and physical data on an individual level. 2014 Elsevier Inc

    Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

    Get PDF
    Background: In this study, we aimed to evaluate the effects of tocilizumab in adult patients admitted to hospital with COVID-19 with both hypoxia and systemic inflammation. Methods: This randomised, controlled, open-label, platform trial (Randomised Evaluation of COVID-19 Therapy [RECOVERY]), is assessing several possible treatments in patients hospitalised with COVID-19 in the UK. Those trial participants with hypoxia (oxygen saturation <92% on air or requiring oxygen therapy) and evidence of systemic inflammation (C-reactive protein ≥75 mg/L) were eligible for random assignment in a 1:1 ratio to usual standard of care alone versus usual standard of care plus tocilizumab at a dose of 400 mg–800 mg (depending on weight) given intravenously. A second dose could be given 12–24 h later if the patient's condition had not improved. The primary outcome was 28-day mortality, assessed in the intention-to-treat population. The trial is registered with ISRCTN (50189673) and ClinicalTrials.gov (NCT04381936). Findings: Between April 23, 2020, and Jan 24, 2021, 4116 adults of 21 550 patients enrolled into the RECOVERY trial were included in the assessment of tocilizumab, including 3385 (82%) patients receiving systemic corticosteroids. Overall, 621 (31%) of the 2022 patients allocated tocilizumab and 729 (35%) of the 2094 patients allocated to usual care died within 28 days (rate ratio 0·85; 95% CI 0·76–0·94; p=0·0028). Consistent results were seen in all prespecified subgroups of patients, including those receiving systemic corticosteroids. Patients allocated to tocilizumab were more likely to be discharged from hospital within 28 days (57% vs 50%; rate ratio 1·22; 1·12–1·33; p<0·0001). Among those not receiving invasive mechanical ventilation at baseline, patients allocated tocilizumab were less likely to reach the composite endpoint of invasive mechanical ventilation or death (35% vs 42%; risk ratio 0·84; 95% CI 0·77–0·92; p<0·0001). Interpretation: In hospitalised COVID-19 patients with hypoxia and systemic inflammation, tocilizumab improved survival and other clinical outcomes. These benefits were seen regardless of the amount of respiratory support and were additional to the benefits of systemic corticosteroids. Funding: UK Research and Innovation (Medical Research Council) and National Institute of Health Research

    Don’t you escape. I’ll tell you my story

    No full text
    Abstract. This paper makes two contributions to increasing the engagement of users in virtual heritage environments by adding virtual living creatures. This work is carried out on the context of models of the Mayan cities of Palenque and Calakmul. Firstly, it proposes a virtual guide system. The guide navigates a virtual world and tells stories about the locations within it, bringing to them its personality and role, so that differently characterised guides will produce different stories. Secondly, it develops an architecture for adding autonomous animals to virtual heritage. It develops an affective component for such animal agents in order to increase the realism of their flocking behaviour and adds a mechanism for transmitting emotion between animals via virtual pheromones, modelled as particles in a free expansion gas.

    Reorganising Artificial Neural Network Topologies

    No full text

    Dealing with creationist challenges: what European biology teachers might expect in the classroom

    No full text
    Creationists are becoming more active in Europe. We expect that European biology teachers will be more frequently challenged by students who introduce creationist misconceptions of evolutionary theory into the classroom. Moreover, research suggests that not all teachers are equally well prepared to deal with them. To make biology teachers aware of what they might be confronted with, we discuss three kinds of misconceptions that are common in creationist literature: misconstruing scientific methodology, making a straw man out of evolutionary theory, and demanding unreasonable evidence. We offer some suggestions as to how to deal with them, but we also note the importance of embedding this approach in a more comprehensive educational program in which students learn to think critically and in which their moral concerns and worldview are taken into account. In addition, we invite biology teachers to reflect on their own knowledge and, if necessary, to refresh it by consulting accessible yet scientifically informed literature. Although our main concern lies with teachers in Europe, our approach might be valuable to biology teachers worldwide
    corecore